Organisation paid for research Program year 2024 Source: CMS Open Payments

Panoramic Science, LLC

Neither a doctor nor a teaching hospital

Research payments

$1,388,621

29 payments

Through program year 2024, Panoramic Science, LLC is reported as receiving $1,388,621 in research payments, across 29 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2024	Research	$1,341,033	26
2023	Research	$47,588	3

Breakdown

Who paid Research payments · program years 2023–2024

AstraZeneca Pharmaceuticals LP $1,388,621 29 payments

Studies the money was for Research payments · program years 2023–2024

a phase 3,randomised,double blind,active controlled study to assess the efficacy,safety and tolerability of baxdrostat in combination with dapagliflozin compared with dapagliflozin alone on chronic kidney disease ckd progression in participants with ckd and high blood pressure $996,594 18 payments
A Randomised,Double Blind,Placebo Controlled,Parallel Group Study to Assess the Efficacy and Safety of Baxdrostat in Participants with Uncontrolled Hypertension on Two or More Medications including Participants with Resistant Hypertension $233,955 5 payments
A Randomised Double-Blind Placebo-Controlled Parallel Group Study to Assess the Effect of Baxdrostat on Ambulatory Blood Pressure in Participants with Resistant Hypertension $124,028 3 payments
TA description Cardiovascular Renal and Metabolism Indications Chronic Kidney Disease Study status Ongoing Phase descripton Phase 3 Category R&D Sponsored Delivery model Internal $34,043 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.